MAM
TMDX icon

Must Asset Management’s Transmedics TMDX Stock Holding History

Must Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.17M Buy
+94,202
New +$6.78M 12.65% 3

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Must Asset Management's TMDX Position: Q3 2023 in Review

Must Asset Management opened a new position in Transmedics (TMDX) in Q3 2023: 94,202 shares worth $5.17M. The stake represents 12.65% of the portfolio and ranks #3 among its holdings.

221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

  • Must Asset Management held 94,202 shares of Transmedics worth $5.17M as of Q3 2023.
  • Transmedics was a new Must Asset Management position in Q3 2023.
  • Transmedics made up 12.65% of Must Asset Management's portfolio in Q3 2023, its #3 holding.
  • 221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on Must Asset Management's 13F filing for Q3 2023, filed 7 Nov 2023.